These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacophore development and application toward the identification of novel, small-molecule autotaxin inhibitors. North EJ; Howard AL; Wanjala IW; Pham TC; Baker DL; Parrill AL J Med Chem; 2010 Apr; 53(8):3095-105. PubMed ID: 20349977 [TBL] [Abstract][Full Text] [Related]
3. Development of an activity-based probe for autotaxin. Cavalli S; Houben AJ; Albers HM; van Tilburg EW; de Ru A; Aoki J; van Veelen P; Moolenaar WH; Ovaa H Chembiochem; 2010 Nov; 11(16):2311-7. PubMed ID: 20941725 [TBL] [Abstract][Full Text] [Related]
4. Discovery and optimization of boronic acid based inhibitors of autotaxin. Albers HM; van Meeteren LA; Egan DA; van Tilburg EW; Moolenaar WH; Ovaa H J Med Chem; 2010 Jul; 53(13):4958-67. PubMed ID: 20536182 [TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution. Saunders LP; Cao W; Chang WC; Albright RA; Braddock DT; De La Cruz EM J Biol Chem; 2011 Aug; 286(34):30130-41. PubMed ID: 21719699 [TBL] [Abstract][Full Text] [Related]
6. Virtual screening approaches for the identification of non-lipid autotaxin inhibitors. Parrill AL; Echols U; Nguyen T; Pham TC; Hoeglund A; Baker DL Bioorg Med Chem; 2008 Feb; 16(4):1784-95. PubMed ID: 18036821 [TBL] [Abstract][Full Text] [Related]
7. Optimization of a pipemidic acid autotaxin inhibitor. Hoeglund AB; Bostic HE; Howard AL; Wanjala IW; Best MD; Baker DL; Parrill AL J Med Chem; 2010 Feb; 53(3):1056-66. PubMed ID: 20041668 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors. Cui P; Tomsig JL; McCalmont WF; Lee S; Becker CJ; Lynch KR; Macdonald TL Bioorg Med Chem Lett; 2007 Mar; 17(6):1634-40. PubMed ID: 17257836 [TBL] [Abstract][Full Text] [Related]
9. Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogs. North EJ; Osborne DA; Bridson PK; Baker DL; Parrill AL Bioorg Med Chem; 2009 May; 17(9):3433-42. PubMed ID: 19345587 [TBL] [Abstract][Full Text] [Related]
10. Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity. Gupte R; Patil R; Liu J; Wang Y; Lee SC; Fujiwara Y; Fells J; Bolen AL; Emmons-Thompson K; Yates CR; Siddam A; Panupinthu N; Pham TC; Baker DL; Parrill AL; Mills GB; Tigyi G; Miller DD ChemMedChem; 2011 May; 6(5):922-35. PubMed ID: 21465666 [TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidylmethanol is a pan lysophosphatidic acid receptor agonist and is produced by autotaxin in blood. Endo T; Kano K; Motoki R; Hama K; Okudaira S; Ishida M; Ogiso H; Tanaka M; Matsuki N; Taguchi R; Kanai M; Shibasaki M; Arai H; Aoki J J Biochem; 2009 Aug; 146(2):283-93. PubMed ID: 19416959 [TBL] [Abstract][Full Text] [Related]
13. Regulation and biological activities of the autotaxin-LPA axis. van Meeteren LA; Moolenaar WH Prog Lipid Res; 2007 Mar; 46(2):145-60. PubMed ID: 17459484 [TBL] [Abstract][Full Text] [Related]